A feedback regulatory loop between methyltransferase PRMT1 and orphan receptor TR3

Nucleic Acids Research

Volumn 37, Issue 3, 2009, Pages 832-848

  Lei, Na Zi ^a   Zhang, Xiao Yan ^a   Chen, Hang Zi ^a   Wang, Yuan ^a   Zhan, Yan Yan ^a   Zheng, Zhong Hui ^a   Shen, Yue Mao ^a   Wu, Qiao ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; DNA; HEPATOCYTE NUCLEAR FACTOR 4; NUCLEAR RECEPTOR COACTIVATOR 2; NUCLEAR RECEPTOR NUR77; NUCLEAR RECEPTOR TR3; PROTEIN ARGININE METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE 1; PROTEIN SAM68; STAT3 PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; PRMT1 PROTEIN, HUMAN; REPRESSOR PROTEIN; STEROID RECEPTOR;

ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; FEEDBACK SYSTEM; GENE REPRESSION; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; ANIMAL; CELL LINE; DRUG ANTAGONISM; DRUG POTENTIATION; METABOLISM; MOUSE MUTANT;

MUS;

ANIMALS; CELL LINE; DNA-BINDING PROTEINS; FEEDBACK, BIOCHEMICAL; HUMANS; MICE; MICE, KNOCKOUT; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN-ARGININE N-METHYLTRANSFERASE; RECEPTORS, STEROID; REPRESSOR PROTEINS;

EID: 63349098780     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn941     Document Type: Article

References (51)

1. Herrmann,F., Lee,J., Bedford,M.T. and Fackelmayer,F.O. (2005) Dynamics of human protein arginine methyltransferase 1(PRMT1) in vivo. J. Biol. Chem., 280, 38005-38010.
2. McBride,A.E. and Silver,P.A. (2001) State of the arg: Protein methylation at arginine comes of age. Cell, 106, 5-8.
3. Gary,J.D. and Clarke,S. (1998) RNA and protein interactions modulated by protein arginine methylation. Prog. Nucleic Acid Res. Mol. Biol., 61, 65-131.
4. Lin,W.J., Gary,J.D., Yang,M.C., Clarke,S. and Herschman,H.R. (1996) The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J. Biol. Chem., 271, 15034-15044.
5. Tang,J., Gary,J.D., Clarke,S. and Herschman,H.R. (1998) PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation. J. Biol. Chem., 273, 16935-16945.
6. Bedford,M.T. and Richard,S. (2005) Arginine methylation an emerging regulator of protein function. Mol. Cell, 18, 263-272.
7. Pawlak,M.R., Scherer,C.A., Chen,J., Roshon,M.J. and Ruley,H.E. (2000) Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable. Mol. Cell. Biol., 20, 4859-4869.
8. Hadzopoulou-Cladaras,M., Kistanova,E., Evagelopoulou,C., Zeng,S., Cladaras,C. and Ladias,J.A. (1997) Functional domains of the nuclear receptor hepatocyte nuclear factor 4. J. Biol. Chem., 272, 539-550.
9. Dhe-Paganon,S., Duda,K., Iwamoto,M., Chi,Y.I. and Shoelson,S.E. (2002) Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand. J. Biol. Chem., 277, 37973-37976.
10. Wisely,G.B., Miller,A.B., Davis,R.G., Thornquest,A.D. Jr., Johnson,R., Spitzer,T., Sefler,A., Shearer,B., Moore,J.T., Miller,A.B. et al. (2002) Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure, 10, 1225-1234.
11. Barrero,M.J. and Malik,S. (2006) Two functional modes of a nuclear receptor-recruited arginine methyltransferase in transcriptional activation. Mol Cell, 24, 233-243.
12. Lee,D.Y., Teyssier,C., Strahl,B.D. and Stallcup,M.R. (2005) Role of protein methylation in regulation of transcription. Endocr. Rev., 26, 147-170.
13. Wysocka,J., Allis,C.D. and Coonrod,S. (2006) Histone arginine methylation and its dynamic regulation. Front. Biosci., 11, 344-355.
14. Singh,V., Miranda,T.B., Jiang,W., Frankel,A., Roemer,M.E., Robb,V.A., Gutmann,D.H., Herschman,H.R., Clarke,S. and Newsham,I.F. (2004) DAL-1/ 4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo. Oncogene, 23, 7761-7771.
15. Jiang,W., Roemer,M.E. and Newsham,I.F. (2005) The tumor suppressor DAL-1/ 4.1B modulates protein arginine N-methyltransferase 5 activity in a substrate-specific manner. Biochem. Biophys. Res. Commun., 329 522-530.
16. Duong,F.H., Christen,V., Berke,J.M., Penna,S.H., Moradpour,D. and Heim,M.H. (2005) Upregulation of protein phosphatase 2Ac by hepatitis C virus modulates NS3 helicase activity through inhibition of protein arginine methyltransferase 1. J. Virol., 79, 15342-15350.
17. Lim,Y., Kwon,Y.H., Won,N.H., Min,B.H., Park,I.S., Paik,W.K. and Kim,S. (2005) Multimerization of expressed protein-arginine methyltransferases during the growth and differentiation of rat liver. Biochim. Biophys. Acta, 1723, 240-247.
18. Dequiedt,F., Kasler,H., Fischle,W., Kiermer,V., Weinstein,M., Herndier,B.G. and Verdin,E. (2003) HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. Immunity, 18, 687-698.
19. Zhao,B.X., Chen,H.Z., Lei,N.Z., Li,G.D., Zhao,W.X., Zhan,Y.Y., Liu,B., Lin,S.C. and Wu,Q. (2006) p53 mediates the negative regulation of MDM2 by orphan receptor TR3. EMBO J., 25, 5703-5715.
20. Zhao,W.X., Tian,M., Zhao,B.X., Li,G.D., Liu,B., Zhan,Y.Y., Chen,H.Z. and Wu,Q. (2007) Orphan receptor TR3 attenuates the p300-induced acetylation of retinoid X receptor-alpha. Mol. Endocrinol., 21, 2877-2889.
21. Li,G.D., Fang,J.X., Chen,H.Z., Luo,J., Zheng,Z.H., Shen,Y.M. and Wu,Q. (2007) Negative regulation of transcription coactivator p300 by orphan receptor TR3. Nucleic Acids Res., 35, 7348-7359.
22. Liu,B., Wu,J.F., Zhan,Y.Y., Chen,H.Z., Zhang,X.Y. and Wu,Q. (2007) Regulation of the orphan receptor TR3 nuclear functions by c-Jun N terminal kinase phosphorylation. Endocrinology, 148, 34-44.
23. Maira,M., Martens,C., Philips,A. and Drouin,J. (1999) Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol, Cell. Biol., 19, 7549-7557.
24. Krull,M., Klucken,A.C., Wuppermann,F.N., Fuhrmann,O., Magerl,C., Seybold,J., Hippenstiel,S., Hegemann,J.H., Jantos,C.A. and Suttorp,N. (1999) Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. J. Immunol., 162 4834-4841.
25. Smith,J.J., Rucknagel,K.P., Schierhorn,A., Tang,J., Nemeth,A., Linder,M., Herschman,H.R. and Wahle,E. (1999) Unusual sites of arginine methylation in Poly(A)-binding protein II and in vitro methylation by protein arginine methyltransferases PRMT1 and PRMT3. J. Biol. Chem. 274, 13229-13234.
26. Klein,S., Carroll,J.A., Chen,Y., Henry,M.F., Henry,P.A., Ortonowski,I.E, Pintucci,G., Beavis,R.C., Burgess,W.H. and Rifkin,D.B. (2000) Biochemical analysis of the arginine methylation of high molecular weight fibroblast growth factor-2. J. Biol. Chem., 275, 3150-3157.
27. Balint,B.L., Szanto,A., Madi,A., Bauer,U.M., Gabor,P., Benko,S., Puskas,L.G., Davies,P.J. and Nagy,L. (2005) Arginine methylation provides epigenetic transcription memory for retinoid-induced differentiation in myeloid cells. Mol. Cell. Biol., 25, 5648-5663.
28. Mu,X. and Chang,C. (2003) TR3 orphan nuclear receptor mediates apoptosis through up-regulating E2F1 in human prostate cancer LNCaP cells. J. Biol. Chem., 278, 42840-42845.
29. Pei,L., Castrillo,A. and Tontonoz,P. (2006) Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol. Endocrinol., 20, 786-794.
30. Wansa,K.D., Harris,J.M. and Muscat,G.E. (2002) The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment. J. Biol. Chem., 277, 33001-33011.
31. Strahl,B.D., Briggs,S.D., Brame,C.J., Caldwell,J.A., Koh,S.S., Ma,H., Cook,R.G., Shabanowitz,J., Hunt,D.F., Stallcup,M.R. et al. (2001) Methylation of histone H4at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1. Curr. Biol., 11, 996-1000.
32. Wang,H., Huang,Z.Q., Xia,L., Feng,Q., Erdjument-Bromage,H., Strahl,B.D., Briggs,S.D., Allis,C.D., Wong,J., Tempst,P. et al. (2001) Methylation of histone H4at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science, 293, 853-857.
33. Rho,J., Choi,S., Seong,Y.R., Choi,J. and Im,D.S. (2001) The arginine-1493 residue in QRRGRTGR1493G motif IV of the hepatitis C virus NS3 helicase domain is essential for NS3 protein methylation by the protein arginine methyltransferase 1. J. Virol., 75, 8031-8044.
34. Cote,J., Boisvert,F.M., Boulanger,M.C., Bedford,M.T. and Richard,S. (2003) Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1. Mol. Biol. Cell, 14, 274-287.
35. Yoo,J.Y., Wang,W., Desiderio,S. and Nathans,D. (2001) Synergistic activity of STAT3 and c-Jun at a specific array of DNA elements in the alpha 2-macroglobulin promoter. J. Biol. Chem., 276, 26421-26429.
36. Zhan,Y., Du,X., Chen,H., Liu,J., Zhao,B., Huang,D., Li,G., Xu,Q., Zhang,M., Weimer,B.C. et al. (2008) Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat. Chem. Biol., 4, 548-556.
37. Chen,D., Ma,H., Hong,H., Koh,S.S., Huang,S.M., Schurter,B.T., Aswad,D.W. and Stallcup,M.R. (1999) Regulation of transcription by a protein methyltransferase. Science, 284, 2174-2177.
38. Koh,S.S., Chen,D., Lee,Y.H. and Stallcup,M.R. (2001) Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J. Biol. Chem., 276, 1089-1098.
39. Rezai-Zadeh,N., Zhang,X., Namour,F., Fejer,G., Wen,Y.D., Yao,Y.L., Gyory,I., Wright,K. and Seto,E. (2003) Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1. Genes Dev., 17, 1019-1029.
40. An,W., Kim,J. and Roeder,R.G. (2004) Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53. Cell, 117, 735-748.
41. Lee,J. and Bedford,M.T. (2002) PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays. EMBO Rep., 3, 268-273.
42. Maira,M., Martens,C., Batsche,E., Gauthier,Y. and Drouin,J. (2003) Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment. Mol. Cell. Biol., 23, 763-776.
43. Berthet,C., Guehenneux,F., Revol,V., Samarut,C., Lukaszewicz,A., Dehay,C., Dumontet,C., Magaud,J.P. and Rouault,J.P. (2002), Interaction of PRMT1 with BTG/TOB proteins in cell signalling: Molecular analysis and functional aspects. Genes Cells, 7, 29-39.
44. Robin-Lespinasse,Y., Sentis,S., Kolytcheff,C., Rostan,M.C., Corbo,L. and Le,R.M. (2007) hCAF1, a new regulator of PRMT1-dependent arginine methylation. J. Cell Sci., 120, 638-647.
45. Hazel,T.G., Nathans,D. and Lau,L.F. (1988) A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc. Natl Acad. Sci. USA, 85, 8444-8448.
46. Passos,D.O., Bressan,G.C., Nery,F.C. and Kobarg,J. (2006) Ki-1/57 interacts with PRMT1 and is a substrate for arginine methylation. FEBS J., 273, 3946-3961.
47. Clarke,S. (1993) Protein methylation. Curr. Opin. Cell. Biol., 5, 977-983.
48. Vallance,P., Leone,A., Calver,A., Collier,J. and Moncada,S. (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet, 339, 572-575.
49. Boger,R.H., Bode-Boger,S.M., Szuba,A., Tsao,P.S., Chan,J.R., Tangphao,O., Blaschke,T.F. and Cooke,J.P. (1998) Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction: Its role in hypercholesterolemia. Circulation, 98 1842-1847.
50. Miyazaki,H., Matsuoka,H., Cooke,J.P., Usui,M., Ueda,S., Okuda,S. and Imaizumi,T. (1999) Endogenous nitric oxide synthase inhibitor: A novel marker of atherosclerosis. Circulation, 99, 1141-1146.
51. Zoccali,C., Bode-Boger,S., Mallamaci,F., Benedetto,F., Tripepi,G., Malatino,L., Cataliotti,A., Bellanuova,I., Fermo,I., Frolich,J. and Boger,R. (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet, 358, 2113-2117.